CervoMed (CRVO) Misses Q2 EPS by 27c

CervoMed (NASDAQ: CRVO) reported Q2 EPS of ($0.27). Revenue for the quarter came in at $3.29 million.

For earnings history and earnings-related data on CervoMed (CRVO) click here.

You May Also Be Interested In

• AeroVironment restates quarterly financials, citing $89M goodwill error
• Piper Sandler on Equity Bancshares (EQBK): 'Investor Day Emphasizes Building Organic Growth Momentum & Differentiation'
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group